Parmax Pharma Ltd.
|
Nine Months RESULTS
|
|
You can view the
Nine Months Results
for the last 5 years.
Market Cap. (Rs.)
|
10.90 Cr.
|
P/BV
|
2.12
|
Book Value (Rs.)
|
13.75
|
52 Week High/Low (Rs.)
|
38/24
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
Bookclosure
|
29/09/2023
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
Net Sales/Income from operations | 6.80 | 9.04 | 11.16 | 18.81 | 16.57 |
Total Income From Operations | 6.80 | 9.04 | 11.16 | 18.81 | 16.57 |
| | | | | |
EXPENDITURE | | | | | |
Consumption of Raw Materials | 2.26 | 6.46 | 2.95 | 10.26 | 8.24 |
Increase/Decrease in Stocks | 1.52 | -4.57 | 0.00 | -0.81 | 0.41 |
Employees Cost | 2.41 | 2.20 | 2.98 | 2.90 | 2.24 |
Depreciation | 1.30 | 1.41 | 1.43 | 1.44 | 0.64 |
Other Expenses | 3.17 | 3.53 | 3.36 | 3.74 | 3.74 |
Total Expenses | 10.67 | 9.03 | 10.72 | 17.52 | 15.27 |
| | | | | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | -3.87 | 0.01 | 0.44 | 1.29 | 1.30 |
Other Income | 0.03 | 0.02 | 0.05 | 0.07 | 0.05 |
P/L Before Interest, Excpt. Items & Tax | -3.84 | 0.04 | 0.49 | 1.36 | 1.35 |
Interest | 0.46 | 0.31 | 0.30 | 0.30 | 0.04 |
P/L Before Exceptional Items & Tax | -4.30 | -0.28 | 0.19 | 1.06 | 1.31 |
P/L Before Tax | -4.30 | -0.28 | 0.19 | 1.06 | 1.31 |
P/L After Tax from Ordinary Activities | -4.30 | -0.28 | 0.19 | 1.06 | 1.31 |
Net Profit/Loss For the Period | -4.30 | -0.28 | 0.19 | 1.06 | 1.31 |
| | | | | |
Equity Share Capital | 3.74 | 3.74 | 3.74 | 3.74 | 3.74 |
EPS Before Extra Ordinary * | | | | | |
Basic EPS (Rs.) | -11.49 | -0.74 | 0.50 | 2.83 | 3.51 |
Diluted EPS (Rs.) | -11.49 | -0.74 | 0.50 | 2.83 | 3.51 |
EPS After Extra Ordinary * | | | | | |
Basic EPS (Rs.) | -11.49 | -0.74 | 0.50 | 2.83 | 3.51 |
Diluted EPS (Rs.) | -11.49 | -0.74 | 0.50 | 2.83 | 3.51 |
| | | | | |
PBITOE Margin (%) | -57.02 | 0.14 | 3.95 | 6.86 | 7.85 |
PBTE Margin (%) | -63.27 | -3.06 | 1.67 | 5.62 | 7.92 |
PBT Margin (%) | -63.27 | -3.06 | 1.67 | 5.62 | 7.92 |
PAT Margin (%) | -63.27 | -3.06 | 1.67 | 5.62 | 7.92 |